References

Add a new dimension of insights to your view of cancer with Guardant Infinity.

Genomics alone provides a narrow view of cancer.
Epigenomic insights are critical to understanding cancer
biology that genomics alone cannot elucidate.1,2

The epigenome can help explain diverse phenotypes that do not
harbor genetic variation3

Within the last decade, up to 42% of FDA-approved therapies were biomarker driven.4

However, among all patients with cancer, >80% are still ineligible for genomic precision medicine approaches.5